Captopril in heart failure. A double blind controlled trial.

J G Cleland, H J Dargie, G P Hodsman, S G Ball, J I Robertson, J J Morton, B W East, I Robertson, G D Murray, G Gillen

The effect of the converting enzyme inhibitor captopril as long term treatment was investigated in 14 patients with severe congestive heart failure in a double blind trial. Captopril reduced plasma concentrations of angiotensin II and noradrenaline, with a converse increase in active renin concentration. Effective renal plasma flow increased and renal vascular resistance fell; glomerular filtration rate did not change. Serum urea and creatinine concentrations rose. Both serum and total body potassium contents increased; there were no long term changes in serum concentration or total body content of sodium. Exercise tolerance was appreciably improved, and dyspnoea and fatigue lessened. Left ventricular end systolic and end diastolic dimensions were reduced. There was an appreciable reduction in complex ventricular ectopic rhythms. Adverse effects were few: weight gain and fluid retention were evident in five patients when captopril was introduced and two patients initially experienced mild postural dizziness; rashes in two patients did not recur when the drug was reintroduced at a lower dose; there was a significant reduction in white cell count overall, but the lowest individual white cell count was 4000 X 10(6)/l. Captopril thus seemed to be of considerable value in the long term treatment of severe cardiac failure.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Bansal, S., Lindenfeld, J., Schrier, R. W. (2009). Sodium Retention in Heart Failure and Cirrhosis: Potential Role of Natriuretic Doses of Mineralocorticoid Antagonist?. Circ Heart Fail 2: 370-376 [Abstract] [Full Text]  
• Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., Michl, K., Oates, J. A., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W. (2009). 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 53: e1-e90 [Full Text]  
• Jessup, M., Abraham, W. T., Casey, D. E., Feldman, A. M., Francis, G. S., Ganiats, T. G., Konstam, M. A., Mancini, D. M., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W. (2009). 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 53: 1343-1382 [Full Text]  
• 2009 WRITING GROUP TO REVIEW NEW EVIDENCE AND UPDA, , Jessup, M., Abraham, W. T., Casey, D. E., Feldman, A. M., Francis, G. S., Ganiats, T. G., Konstam, M. A., Mancini, D. M., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W. (2009). 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation. Circulation 119: 1977-2016 [Full Text]  
• 2005 WRITING COMMITTEE MEMBERS, , Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., Michl, K., Oates, J. A., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W. (2009). 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation. Circulation 119: e391-e479 [Full Text]  
• Beygui, F., Collet, J.-P., Benoliel, J.-J., Vignolles, N., Dumaine, R., Barthelemy, O., Montalescot, G. (2006). High Plasma Aldosterone Levels on Admission Are Associated With Death in Patients Presenting With Acute ST-Elevation Myocardial Infarction. Circulation 114: 2604-2610 [Abstract] [Full Text]  
• Developed in Collaboration With the American Colle, , Endorsed by the Heart Rhythm Society, , Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., Michl, K., Oates, J. A., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W., Antman, E. M., Smith, S. C. Jr, Adams, C. D., Anderson, J. L., Faxon, D. P., Fuster, V., Halperin, J. L., Hiratzka, L. F., Hunt, S. A., Jacobs, A. K., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B. (2005). ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult--Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 46: 1116-1143 [Full Text]  
• van der Meer, P., Lipsic, E., Westenbrink, B. D., van de Wal, R. M.A., Schoemaker, R. G., Vellenga, E., van Veldhuisen, D. J., Voors, A. A., van Gilst, W. H. (2005). Levels of Hematopoiesis Inhibitor N-Acetyl-Seryl-Aspartyl-Lysyl-Proline Partially Explain the Occurrence of Anemia in Heart Failure. Circulation 112: 1743-1747 [Abstract] [Full Text]  
• Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., Michl, K., Oates, J. A., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W., Antman, E. M., Smith, S. C. Jr, Adams, C. D., Anderson, J. L., Faxon, D. P., Fuster, V., Halperin, J. L., Hiratzka, L. F., Hunt, S. A., Jacobs, A. K., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B. (2005). ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult--Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society. Circulation 112: 1825-1852 [Full Text]  
• Abdulla, J., Abildstrom, S. Z., Christensen, E., Kober, L., Torp-Pedersen, C. (2004). A meta-analysis of the effect of angiotensin-converting enzyme inhibitors on functional capacity in patients with symptomatic left ventricular systolic dysfunction. Eur J Heart Fail 6: 927-935 [Abstract] [Full Text]  
• Connell, J. (2004). Review: Aldosterone -- the future challenge in cardiovascular disease?. British Journal of Diabetes & Vascular Disease 4: 370-376 [Abstract]  
• Domanski, M., Norman, J., Pitt, B., Haigney, M., Hanlon, S., Peyster, E. (2003). Diuretic use, progressive heart failure, and death in patients in the studies of left ventricular dysfunction (SOLVD). J Am Coll Cardiol 42: 705-708 [Abstract] [Full Text]  
• Cicoira, M., Zanolla, L., Rossi, A., Golia, G., Franceschini, L., Brighetti, G., Marino, P., Zardini, P. (2002). Long-term, dose-dependent effects of spironolactone on left ventricular function and exercise tolerance in patients with chronic heart failure. J Am Coll Cardiol 40: 304-310 [Abstract] [Full Text]  
• Ellis, G. R., Nightingale, A. K., Blackman, D. J., Anderson, R. A., Mumford, C., Timmins, G., Lang, D., Jackson, S. K., Penney, M. D., Lewis, M. J., Frenneaux, M. P., Morris-Thurgood, J. (2002). Addition of candesartan to angiotensin converting enzyme inhibitor therapy in patients with chronic heart failure does not reduce levels of oxidative stress. Eur J Heart Fail 4: 193-199 [Abstract] [Full Text]  
• Cicoira, M., Zanolla, L., Rossi, A., Golia, G., Franceschini, L., Cabrini, G., Bonizzato, A., Graziani, M., Anker, S. D., Coats, A. J. S., Zardini, P. (2001). Failure of aldosterone suppression despite angiotensin-converting enzyme (ACE) inhibitor administration in chronic heart failure is associated with ACE DD genotype. J Am Coll Cardiol 37: 1808-1812 [Abstract] [Full Text]  
• Tsutamoto, T., Wada, A., Maeda, K., Mabuchi, N., Hayashi, M., Tsutsui, T., Ohnishi, M., Sawaki, M., Fujii, M., Matsumoto, T., Matsui, T., Kinoshita, M. (2001). Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure. J Am Coll Cardiol 37: 1228-1233 [Abstract] [Full Text]  
• Sanoski, C. A. (2001). The Year in Review: Cardiology. Journal of Pharmacy Practice 14: 18-40 [Abstract]  
• Gondo, N., Kumagai, K., Nakashima, H., Saku, K. (2001). Angiotensin II provokes cesium-induced ventricular tachyarrhythmias. Cardiovasc Res 49: 381-390 [Abstract] [Full Text]  
• Tsutamoto, T., Wada, A., Maeda, K., Mabuchi, N., Hayashi, M., Tsutsui, T., Ohnishi, M., Sawaki, M., Fujii, M., Matsumoto, T., Horie, H., Sugimoto, Y., Kinoshita, M. (2000). Spironolactone inhibits the transcardiac extraction of aldosterone in patients with congestive heart failure. J Am Coll Cardiol 36: 838-844 [Abstract] [Full Text]  
• Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., Wittes, J., The Randomized Aldactone Evaluation Study Investig, (1999). The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure. NEJM 341: 709-717 [Abstract] [Full Text]  
• Zisman, L. S., Asano, K., Dutcher, D. L., Ferdensi, A., Robertson, A. D., Jenkin, M., Bush, E. W., Bohlmeyer, T., Perryman, M. B., Bristow, M. R. (1998). Differential Regulation of Cardiac Angiotensin Converting Enzyme Binding Sites and AT1 Receptor Density in the Failing Human Heart. Circulation 98: 1735-1741 [Abstract] [Full Text]  
• Stephens, N., Drinkhill, M. J., Hall, A. S., Ball, S. G., Heagerty, A. M. (1998). Structure and in vitro function of human subcutaneous small arteries in mild heart failure. Am. J. Physiol. Cell Physiol. 274: C1298-C1305 [Abstract] [Full Text]  
• Siogas, K, Pappas, S, Graekas, G, Goudevenos, J, Liapi, G, Sideris, D A (1998). Segmental wall motion abnormalities alter vulnerability to ventricular ectopic beats associated with acute increases in aortic pressure in patients with underlying coronary artery disease. Heart 79: 268-273 [Abstract] [Full Text]  
• Townend, J. N., Al-Ani, M., West, J. N., Littler, W. A., Coote, J. H. (1995). Modulation of Cardiac Autonomic Control in Humans by Angiotensin II. Hypertension 25: 1270-1275 [Abstract] [Full Text]  
• Dargie, H J, McMurray, J J V (1994). Fortnightly Review: Diagnosis and management of heart failure. BMJ 308: 321-328 [Abstract] [Full Text]  
• Oster, J. R., Materson, B. J. (1992). Renal and Electrolyte Complications of Congestive Heart Failure and Effects of Therapy With Angiotensin-Converting Enzyme Inhibitors. Arch Intern Med 152: 704-710 [Abstract]  
• Deedwania, P. C. (1990). Angiotensin-Converting Enzyme Inhibitors in Congestive Heart Failure. Arch Intern Med 150: 1798-1805 [Abstract]  
• Jaeschke, R., Guyatt, G. H. (1989). Medical Therapy for Chronic Congestive Heart Failure. ANN INTERN MED 110: 758-760 [Abstract]  
• Marantz, P. R., Alderman, M. H., Tobin, J. N. (1988). Diagnostic Heterogeneity in Clinical Trials for Congestive Heart Failure. ANN INTERN MED 109: 55-61 [Abstract]  
• Mulrow, C. D., Mulrow, J. P., Linn, W. D., Aguilar, C., Ramirez, G. (1988). Relative Efficacy of Vasodilator Therapy in Chronic Congestive Heart Failure: Implications of Randomized Trials. JAMA 259: 3422-3426 [Abstract]  
• PACKER, M., LEE, W. H., MEDINA, N., YUSHAK, M., KESSLER, P. D. (1987). Functional Renal Insufficiency During Long-Term Therapy with Captopril and Enalapril in Severe Chronic Heart Failure. ANN INTERN MED 106: 346-354 [Abstract]  
• PACKER, M., LEE, W. H., MEDINA, N., YUSHAK, M. (1986). Influence of Renal Function on the Hemodynamic and Clinical Responses to Long-Term Captopril Therapy in Severe Chronic Heart Failure. ANN INTERN MED 104: 147-154 [Abstract]